Alembic Limited (IN:ALEMBICLTD)
:ALEMBICLTD
ALEMBICLTD Stock Chart & Stats
₹103.40
-₹1.48(-1.12%)
At close: 4:00 PM EST
₹103.40
-₹1.48(-1.12%)
Day’s Range― - ―
52-Week Range₹70.64 - ₹125.70
Previous CloseN/A
Volume165.88K
Average Volume (3M)22.23K
Market Cap
₹20.58B
Enterprise Value₹20.75B
Total Cash (Recent Filing)₹888.10M
Total Debt (Recent Filing)₹125.80M
Price to Earnings (P/E)10.8
Beta1.51
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.36%
Share Statistics
EPS (TTM)2.34
Shares Outstanding256,781,830
10 Day Avg. Volume15,327
30 Day Avg. Volume22,227
Financial Highlights & Ratios
PEG Ratio0.53
Price to Book (P/B)1.10
Price to Sales (P/S)11.55
P/FCF Ratio71.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Diversified Business Model & Vertical IntegrationAlembic's mix of branded formulations, international generics and an in‑house API capability creates multiple durable revenue streams. Vertical integration reduces input cost and supply risk, supporting margin resilience and strategic flexibility across markets over the next 2-6 months.
Strong Revenue Growth And High Gross MarginsVery strong top-line growth alongside elevated gross and operating margins indicates scalable product franchises and effective cost control. Durable margin structure and revenue momentum support reinvestment capacity for R&D and market expansion over a multi-month horizon.
Very Conservative Balance Sheet And Low LeverageExtremely low leverage and a high equity ratio provide financial flexibility for capex, M&A or to withstand industry cycles. A conservative capital structure reduces refinancing risk and preserves optionality for strategic investments over the medium term.
Bears Say
Profitability Sustainability ConcernsThe outsized net margin appears driven by non-recurring items, making headline profitability unreliable. If one-time gains reverse, recurring earnings and metrics like ROE may fall, complicating longer-term earnings visibility and capital allocation decisions.
Weak Cash Conversion Despite Positive FCFLow conversion of profits into operating and free cash flow limits internally available funds for working capital, R&D and dividends. Reliance on accounting earnings over cash generation raises funding risk for growth initiatives or payouts in the 2-6 month horizon.
Regulatory And Commercial Risk In International GenericsCross-border generics growth depends on timely approvals and competitive launches. Delays, failed approvals or aggressive competitor pricing can materially reduce overseas sales and margins, creating structural volatility in growth and profitability over the medium term.
Alembic Limited News
ALEMBICLTD FAQ
What was Alembic Limited’s price range in the past 12 months?
Alembic Limited lowest stock price was ₹70.64 and its highest was ₹125.70 in the past 12 months.
What is Alembic Limited’s market cap?
Alembic Limited’s market cap is ₹20.58B.
When is Alembic Limited’s upcoming earnings report date?
Alembic Limited’s upcoming earnings report date is May 07, 2026 which is in 30 days.
How were Alembic Limited’s earnings last quarter?
Alembic Limited released its earnings results on Feb 12, 2026. The company reported ₹2.342 earnings per share for the quarter, beating the consensus estimate of N/A by ₹2.342.
Is Alembic Limited overvalued?
According to Wall Street analysts Alembic Limited’s price is currently Overvalued.
Does Alembic Limited pay dividends?
Alembic Limited pays a Annually dividend of ₹2.4 which represents an annual dividend yield of 2.36%. See more information on Alembic Limited dividends here
What is Alembic Limited’s EPS estimate?
Alembic Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alembic Limited have?
Alembic Limited has 256,781,830 shares outstanding.
What happened to Alembic Limited’s price movement after its last earnings report?
Alembic Limited reported an EPS of ₹2.342 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.726%.
Which hedge fund is a major shareholder of Alembic Limited?
Currently, no hedge funds are holding shares in IN:ALEMBICLTD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alembic Limited
Alembic Limited engages in the manufacturing and marketing of fermentation and chemistry based active pharmaceuticals ingredients (API). It operates through API and Real Estate segments. The company is also involved in the construction of residential and commercial real estate projects; provision of project management and marketing consultancy services; and leasing of commercial properties. In addition, it operates co-generation plants with a total capacity of 11 MW; and wind power plants with a total capacity of 5 MW. The company also exports its products. Alembic Limited was founded in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Limited.
Technical Analysis
Alkem Laboratories Ltd.
―
Alembic Pharmaceuticals Limited
―
Aurobindo Pharma Ltd
―
Glenmark Pharmaceuticals Limited
―
IPCA Laboratories Limited
―